45 CFR § 180 compliance
B · 85
This hospital published most of what § 180 requires.
●Machine-readable file published
●Gross / standard charges
●Discounted cash price
●Payer-specific negotiated rates
○Min / max negotiated charges
●Free, public, no login required
Procedures listed
128,136
Insurances with rates
41
CPT / HCPCS codes
44,990
Source MRF
Most expensive procedures (gross)
00078-0846-19
$582,439
TISAGENLECLEUCEL 0.2 X10EXP6 TO 2.5X10EXP8 CELL INTRAVENOUS SUSPENSION
Gross
$1,903,396
00078-0958-19
$582,439
TISAGENLECLEUCEL 0.6 X 10EXP8 TO 6 X10EXP8 CELL INTRAVENOUS SUSPENSION
Gross
$1,903,396
00078-0846-19
$582,439
TISAGENLECLEUCEL 0.2 X10EXP6 TO 2.5X10EXP8 CELL INTRAVENOUS SUSPENSION
Gross
$1,903,396
00078-0958-19
$582,439
TISAGENLECLEUCEL 0.6 X 10EXP8 TO 6 X10EXP8 CELL INTRAVENOUS SUSPENSION
Gross
$1,903,396
73153-0900-01
$569,076
LISOCABTAGENE MARALEUCEL 1.5 X 10EXP6 TO 70 X 10EXP6 CELL/ML IV SUSP
Gross
$1,859,726
73153-0900-01
$569,076
LISOCABTAGENE MARALEUCEL 1.5 X 10EXP6 TO 70 X 10EXP6 CELL/ML IV SUSP
Gross
$1,859,726
59572-0515-01
$565,823
IDECABTAGENE VICLEUCEL 300 X 10EXP6 TO 510 X 10EXP6 CELL IV SUSPENSION
Gross
$1,849,094
59572-0515-02
$565,823
IDECABTAGENE VICLEUCEL 300 X 10EXP6 TO 510 X 10EXP6 CELL IV SUSPENSION
Gross
$1,849,094
59572-0515-03
$565,823
IDECABTAGENE VICLEUCEL 300 X 10EXP6 TO 510 X 10EXP6 CELL IV SUSPENSION
Gross
$1,849,094
59572-0515-01
$565,823
IDECABTAGENE VICLEUCEL 300 X 10EXP6 TO 510 X 10EXP6 CELL IV SUSPENSION
Gross
$1,849,094
59572-0515-02
$565,823
IDECABTAGENE VICLEUCEL 300 X 10EXP6 TO 510 X 10EXP6 CELL IV SUSPENSION
Gross
$1,849,094
59572-0515-03
$565,823
IDECABTAGENE VICLEUCEL 300 X 10EXP6 TO 510 X 10EXP6 CELL IV SUSPENSION
Gross
$1,849,094
57894-0111-01
$559,121
CILTACABTAGENE AUTOLEUCEL 0.5 X 10EXP6 TO 1X 10EXP8 CELL IV SUSPENSION
Gross
$1,827,194
57894-0111-02
$559,121
CILTACABTAGENE AUTOLEUCEL 0.5 X 10EXP6 TO 1X 10EXP8 CELL IV SUSPENSION
Gross
$1,827,194
57894-0111-01
$559,121
CILTACABTAGENE AUTOLEUCEL 0.5 X 10EXP6 TO 1X 10EXP8 CELL IV SUSPENSION
Gross
$1,827,194
57894-0111-02
$559,121
CILTACABTAGENE AUTOLEUCEL 0.5 X 10EXP6 TO 1X 10EXP8 CELL IV SUSPENSION
Gross
$1,827,194
71287-0119-01
$539,334
AXICABTAGENE CILOLEUCEL INTRAVENOUS SUSPENSION
Gross
$1,762,530
71287-0119-02
$539,334
AXICABTAGENE CILOLEUCEL INTRAVENOUS SUSPENSION
Gross
$1,762,530
71287-0119-01
$539,334
AXICABTAGENE CILOLEUCEL INTRAVENOUS SUSPENSION
Gross
$1,762,530
71287-0119-02
$539,334
AXICABTAGENE CILOLEUCEL INTRAVENOUS SUSPENSION
Gross
$1,762,530
71287-0219-01
$494,802
BREXUCABTAGENE AUTOLEUCEL 2X 10EXP6 TO 2X 10EXP8 CELL IV SUSPENSION
Gross
$1,617,000
71287-0219-02
$494,802
BREXUCABTAGENE AUTOLEUCEL 2X 10EXP6 TO 2X 10EXP8 CELL IV SUSPENSION
Gross
$1,617,000
71287-0220-01
$494,802
BREXUCABTAGENE AUTOLEUCEL 1X 10EXP6 TO 1X 10EXP8 CELL IV SUSPENSION
Gross
$1,617,000
71287-0220-02
$494,802
BREXUCABTAGENE AUTOLEUCEL 1X 10EXP6 TO 1X 10EXP8 CELL IV SUSPENSION
Gross
$1,617,000
71287-0219-01
$494,802
BREXUCABTAGENE AUTOLEUCEL 2X 10EXP6 TO 2X 10EXP8 CELL IV SUSPENSION
Gross
$1,617,000
71287-0219-02
$494,802
BREXUCABTAGENE AUTOLEUCEL 2X 10EXP6 TO 2X 10EXP8 CELL IV SUSPENSION
Gross
$1,617,000
71287-0220-01
$494,802
BREXUCABTAGENE AUTOLEUCEL 1X 10EXP6 TO 1X 10EXP8 CELL IV SUSPENSION
Gross
$1,617,000
71287-0220-02
$494,802
BREXUCABTAGENE AUTOLEUCEL 1X 10EXP6 TO 1X 10EXP8 CELL IV SUSPENSION
Gross
$1,617,000
64406-0058-01
$152,123
NUSINERSEN (PF) 12 MG/5 ML INTRATHECAL SOLUTION
Gross
$497,132
64406-0058-01
$152,123
NUSINERSEN (PF) 12 MG/5 ML INTRATHECAL SOLUTION
Gross
$497,132
69468-0151-20
$80,325
URIDINE TRIACETATE 10 GRAM ORAL GRANULES IN PACKET
Gross
$262,500
69468-0151-20
$80,325
URIDINE TRIACETATE 10 GRAM ORAL GRANULES IN PACKET
Gross
$262,500
55566-1050-01
$65,224
NADOFARAGENE FIRADENOVEC-VNCG 3X10EXP11 VP/ML INTRAVESICAL SUSPENSION
Gross
$213,150
55566-1050-01
$65,224
NADOFARAGENE FIRADENOVEC-VNCG 3X10EXP11 VP/ML INTRAVESICAL SUSPENSION
Gross
$213,150
75987-0150-01
$50,069
INEBILIZUMAB-CDON 10 MG/ML INTRAVENOUS SOLUTION
Gross
$163,623
75987-0150-03
$50,069
INEBILIZUMAB-CDON 10 MG/ML INTRAVENOUS SOLUTION
Gross
$163,623
75987-0150-01
$50,069
INEBILIZUMAB-CDON 10 MG/ML INTRAVENOUS SOLUTION
Gross
$163,623
75987-0150-03
$50,069
INEBILIZUMAB-CDON 10 MG/ML INTRAVENOUS SOLUTION
Gross
$163,623
71336-1001-01
$47,010
GIVOSIRAN 189 MG/ML SUBCUTANEOUS SOLUTION
Gross
$153,629
71336-1001-01
$47,010
GIVOSIRAN 189 MG/ML SUBCUTANEOUS SOLUTION
Gross
$153,629
50633-0210-11
$46,303
GLUCARPIDASE 1,000 UNIT INTRAVENOUS SOLUTION
Gross
$151,316
50633-0210-11
$46,303
GLUCARPIDASE 1,000 UNIT INTRAVENOUS SOLUTION
Gross
$151,316
24338-0050-08
$45,239
CARMUSTINE IN POLIFEPROSAN 7.7 MG WAFER FOR IMPLANT
Gross
$147,840
24338-0050-08
$45,239
CARMUSTINE IN POLIFEPROSAN 7.7 MG WAFER FOR IMPLANT
Gross
$147,840
55980
$42,994
INTERSEX SURGERY, FEMALE TO MALE
Gross
$140,504
55980
$42,994
INTERSEX SURGERY, FEMALE TO MALE
Gross
$140,504
00310-4535-30
$41,769
TREMELIMUMAB-ACTL 20 MG/ML INTRAVENOUS SOLUTION
Gross
$136,500
00310-4535-30
$41,769
TREMELIMUMAB-ACTL 20 MG/ML INTRAVENOUS SOLUTION
Gross
$136,500
66658-0510-01
$38,894
EMAPALUMAB-LZSG 5 MG/ML INTRAVENOUS SOLUTION
Gross
$127,106
66658-0510-01
$38,894
EMAPALUMAB-LZSG 5 MG/ML INTRAVENOUS SOLUTION
Gross
$127,106
| Code | Description | Gross | Cash | Min payer | Max payer | # insurers |
|---|---|---|---|---|---|---|
| 00078-0846-19 | TISAGENLECLEUCEL 0.2 X10EXP6 TO 2.5X10EXP8 CELL INTRAVENOUS SUSPENSION | $1,903,396 | $582,439 | — | — | 9 |
| 00078-0958-19 | TISAGENLECLEUCEL 0.6 X 10EXP8 TO 6 X10EXP8 CELL INTRAVENOUS SUSPENSION | $1,903,396 | $582,439 | — | — | 9 |
| 00078-0846-19 | TISAGENLECLEUCEL 0.2 X10EXP6 TO 2.5X10EXP8 CELL INTRAVENOUS SUSPENSION | $1,903,396 | $582,439 | — | — | 16 |
| 00078-0958-19 | TISAGENLECLEUCEL 0.6 X 10EXP8 TO 6 X10EXP8 CELL INTRAVENOUS SUSPENSION | $1,903,396 | $582,439 | — | — | 16 |
| 73153-0900-01 | LISOCABTAGENE MARALEUCEL 1.5 X 10EXP6 TO 70 X 10EXP6 CELL/ML IV SUSP | $1,859,726 | $569,076 | — | — | 9 |
| 73153-0900-01 | LISOCABTAGENE MARALEUCEL 1.5 X 10EXP6 TO 70 X 10EXP6 CELL/ML IV SUSP | $1,859,726 | $569,076 | — | — | 16 |
| 59572-0515-01 | IDECABTAGENE VICLEUCEL 300 X 10EXP6 TO 510 X 10EXP6 CELL IV SUSPENSION | $1,849,094 | $565,823 | — | — | 9 |
| 59572-0515-02 | IDECABTAGENE VICLEUCEL 300 X 10EXP6 TO 510 X 10EXP6 CELL IV SUSPENSION | $1,849,094 | $565,823 | — | — | 9 |
| 59572-0515-03 | IDECABTAGENE VICLEUCEL 300 X 10EXP6 TO 510 X 10EXP6 CELL IV SUSPENSION | $1,849,094 | $565,823 | — | — | 9 |
| 59572-0515-01 | IDECABTAGENE VICLEUCEL 300 X 10EXP6 TO 510 X 10EXP6 CELL IV SUSPENSION | $1,849,094 | $565,823 | — | — | 16 |
| 59572-0515-02 | IDECABTAGENE VICLEUCEL 300 X 10EXP6 TO 510 X 10EXP6 CELL IV SUSPENSION | $1,849,094 | $565,823 | — | — | 16 |
| 59572-0515-03 | IDECABTAGENE VICLEUCEL 300 X 10EXP6 TO 510 X 10EXP6 CELL IV SUSPENSION | $1,849,094 | $565,823 | — | — | 16 |
| 57894-0111-01 | CILTACABTAGENE AUTOLEUCEL 0.5 X 10EXP6 TO 1X 10EXP8 CELL IV SUSPENSION | $1,827,194 | $559,121 | — | — | 9 |
| 57894-0111-02 | CILTACABTAGENE AUTOLEUCEL 0.5 X 10EXP6 TO 1X 10EXP8 CELL IV SUSPENSION | $1,827,194 | $559,121 | — | — | 9 |
| 57894-0111-01 | CILTACABTAGENE AUTOLEUCEL 0.5 X 10EXP6 TO 1X 10EXP8 CELL IV SUSPENSION | $1,827,194 | $559,121 | — | — | 16 |
| 57894-0111-02 | CILTACABTAGENE AUTOLEUCEL 0.5 X 10EXP6 TO 1X 10EXP8 CELL IV SUSPENSION | $1,827,194 | $559,121 | — | — | 16 |
| 71287-0119-01 | AXICABTAGENE CILOLEUCEL INTRAVENOUS SUSPENSION | $1,762,530 | $539,334 | — | — | 9 |
| 71287-0119-02 | AXICABTAGENE CILOLEUCEL INTRAVENOUS SUSPENSION | $1,762,530 | $539,334 | — | — | 9 |
| 71287-0119-01 | AXICABTAGENE CILOLEUCEL INTRAVENOUS SUSPENSION | $1,762,530 | $539,334 | — | — | 16 |
| 71287-0119-02 | AXICABTAGENE CILOLEUCEL INTRAVENOUS SUSPENSION | $1,762,530 | $539,334 | — | — | 16 |
| 71287-0219-01 | BREXUCABTAGENE AUTOLEUCEL 2X 10EXP6 TO 2X 10EXP8 CELL IV SUSPENSION | $1,617,000 | $494,802 | — | — | 9 |
| 71287-0219-02 | BREXUCABTAGENE AUTOLEUCEL 2X 10EXP6 TO 2X 10EXP8 CELL IV SUSPENSION | $1,617,000 | $494,802 | — | — | 9 |
| 71287-0220-01 | BREXUCABTAGENE AUTOLEUCEL 1X 10EXP6 TO 1X 10EXP8 CELL IV SUSPENSION | $1,617,000 | $494,802 | — | — | 9 |
| 71287-0220-02 | BREXUCABTAGENE AUTOLEUCEL 1X 10EXP6 TO 1X 10EXP8 CELL IV SUSPENSION | $1,617,000 | $494,802 | — | — | 9 |
| 71287-0219-01 | BREXUCABTAGENE AUTOLEUCEL 2X 10EXP6 TO 2X 10EXP8 CELL IV SUSPENSION | $1,617,000 | $494,802 | — | — | 16 |
| 71287-0219-02 | BREXUCABTAGENE AUTOLEUCEL 2X 10EXP6 TO 2X 10EXP8 CELL IV SUSPENSION | $1,617,000 | $494,802 | — | — | 16 |
| 71287-0220-01 | BREXUCABTAGENE AUTOLEUCEL 1X 10EXP6 TO 1X 10EXP8 CELL IV SUSPENSION | $1,617,000 | $494,802 | — | — | 16 |
| 71287-0220-02 | BREXUCABTAGENE AUTOLEUCEL 1X 10EXP6 TO 1X 10EXP8 CELL IV SUSPENSION | $1,617,000 | $494,802 | — | — | 16 |
| 64406-0058-01 | NUSINERSEN (PF) 12 MG/5 ML INTRATHECAL SOLUTION | $497,132 | $152,123 | — | — | 9 |
| 64406-0058-01 | NUSINERSEN (PF) 12 MG/5 ML INTRATHECAL SOLUTION | $497,132 | $152,123 | — | — | 16 |
| 69468-0151-20 | URIDINE TRIACETATE 10 GRAM ORAL GRANULES IN PACKET | $262,500 | $80,325 | — | — | 9 |
| 69468-0151-20 | URIDINE TRIACETATE 10 GRAM ORAL GRANULES IN PACKET | $262,500 | $80,325 | — | — | 16 |
| 55566-1050-01 | NADOFARAGENE FIRADENOVEC-VNCG 3X10EXP11 VP/ML INTRAVESICAL SUSPENSION | $213,150 | $65,224 | — | — | 9 |
| 55566-1050-01 | NADOFARAGENE FIRADENOVEC-VNCG 3X10EXP11 VP/ML INTRAVESICAL SUSPENSION | $213,150 | $65,224 | — | — | 16 |
| 75987-0150-01 | INEBILIZUMAB-CDON 10 MG/ML INTRAVENOUS SOLUTION | $163,623 | $50,069 | — | — | 9 |
| 75987-0150-03 | INEBILIZUMAB-CDON 10 MG/ML INTRAVENOUS SOLUTION | $163,623 | $50,069 | — | — | 9 |
| 75987-0150-01 | INEBILIZUMAB-CDON 10 MG/ML INTRAVENOUS SOLUTION | $163,623 | $50,069 | — | — | 16 |
| 75987-0150-03 | INEBILIZUMAB-CDON 10 MG/ML INTRAVENOUS SOLUTION | $163,623 | $50,069 | — | — | 16 |
| 71336-1001-01 | GIVOSIRAN 189 MG/ML SUBCUTANEOUS SOLUTION | $153,629 | $47,010 | — | — | 9 |
| 71336-1001-01 | GIVOSIRAN 189 MG/ML SUBCUTANEOUS SOLUTION | $153,629 | $47,010 | — | — | 16 |
| 50633-0210-11 | GLUCARPIDASE 1,000 UNIT INTRAVENOUS SOLUTION | $151,316 | $46,303 | — | — | 9 |
| 50633-0210-11 | GLUCARPIDASE 1,000 UNIT INTRAVENOUS SOLUTION | $151,316 | $46,303 | — | — | 16 |
| 24338-0050-08 | CARMUSTINE IN POLIFEPROSAN 7.7 MG WAFER FOR IMPLANT | $147,840 | $45,239 | — | — | 9 |
| 24338-0050-08 | CARMUSTINE IN POLIFEPROSAN 7.7 MG WAFER FOR IMPLANT | $147,840 | $45,239 | — | — | 16 |
| 55980 | INTERSEX SURGERY, FEMALE TO MALE | $140,504 | $42,994 | — | — | 9 |
| 55980 | INTERSEX SURGERY, FEMALE TO MALE | $140,504 | $42,994 | — | — | 16 |
| 00310-4535-30 | TREMELIMUMAB-ACTL 20 MG/ML INTRAVENOUS SOLUTION | $136,500 | $41,769 | — | — | 9 |
| 00310-4535-30 | TREMELIMUMAB-ACTL 20 MG/ML INTRAVENOUS SOLUTION | $136,500 | $41,769 | — | — | 16 |
| 66658-0510-01 | EMAPALUMAB-LZSG 5 MG/ML INTRAVENOUS SOLUTION | $127,106 | $38,894 | — | — | 9 |
| 66658-0510-01 | EMAPALUMAB-LZSG 5 MG/ML INTRAVENOUS SOLUTION | $127,106 | $38,894 | — | — | 16 |
Showing top 50 of 128,136 priced procedures, sorted by gross charge.
Data straight from this hospital's federally-mandated machine-readable file (45 CFR § 180). The compliance grade reflects how completely the hospital published the six required data elements, not the quality of care.